Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Tirzepatide has shown slightly higher average weight loss in head-to-head trials, but it's also typically more expensive and may have a different side effect profile
Product selection should be based on internal laboratory requirements, research context and procurement needs
Treat this as conservative protocol planning
Conversely, if you are okay with compounded medications, either option could work
"Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression"
For translational applications, sustained intranasal delivery aligns far closer with canonical, long-term longevity phenotypes Source: Open Access Paper: Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs Institution: University of Washington, Seattle, WA Country: USA Journal: bioRxiv (Preprint) Impact Evaluation: The impact score of this journal is 0 (as a preprint server without a formal Clarivate index)
US$ 29.61
US$ 25.86
US$ 24.66
US$ 22.30
